Biolife Sciences (Biolife Sciences) EPS (Basic) : $-825.02 (TTM As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences EPS (Basic)?

Biolife Sciences's basic earnings per share (Basic EPS) for the three months ended in May. 2008 was $-150.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in May. 2008 was $-825.02.

Biolife Sciences's EPS (Diluted) for the three months ended in May. 2008 was $-150.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in May. 2008 was $-825.02.

Biolife Sciences's EPS without NRI for the three months ended in May. 2008 was $-91.99. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in May. 2008 was -430.45.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Biolife Sciences EPS (Basic) Historical Data

The historical data trend for Biolife Sciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences EPS (Basic) Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

EPS (Basic)

-15.00

-975.02

-150.00

-900.02

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
EPS (Basic)	Get a 7-Day Free Trial										-225.01	-150.00	-450.01	-75.00	-150.00

Biolife Sciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Biolife Sciences's Basic EPS for the fiscal year that ended in Nov. 2007 is calculated as

Basic EPS (A: Nov. 2007 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-2.046	-	0)	/	0.002
	=	-1,023.00

Biolife Sciences's Basic EPS for the quarter that ended in May. 2008 is calculated as

Basic EPS (Q: May. 2008 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.842	-	0)	/	0.005
	=	-168.40

EPS (Basic) for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-825.02

Biolife Sciences (OTCPK:BLFE) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Biolife Sciences EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020